Evidence map›Paper›PMID 26856225›Full record

ReviewAmerican heart journal2016

Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches.

Henry Klar Yaggi, Murray A Mittleman, Dawn M Bravata, John Concato, James Ware, Catherine M Stoney, Susan Redline

Abstract readReview
In one paragraph

Review in American heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Effect of continuous positive airway pressure treatment on ambulatory blood pressures in high-risk sleep apnea patients: a randomized controlled trial.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Sleep Apnea in Patients Hospitalized With Acute Ischemic Stroke: Underrecognition and Associated Clinical Outcomes.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Article
  15. Validated Measures of Insomnia, Function, Sleepiness, and Nasal Obstruction in a CPAP Alternatives Clinic Population.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
    Article
  16. Article
  17. Wake-up Call to Identify Obstructive Sleep Apnea in Patients with Ischemic Strokes.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Henry Klar YaggiDepartment of Medicine, Yale School of Medicine, New Haven, CT; VA Clinical Epidemiology Research Center, VA Connecticut HCS, West Haven, CT. Electronic address: henry.yaggi@yale.edu.
Murray A MittlemanDepartment of Medicine, Beth Israel Deaconess, Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Dawn M BravataVA Center of Excellence on Implementing Evidence-Based Practice, Richard L. Roudebush VA Medical Center, Indianapolis, IN; Department of Medicine, Indiana School of Medicine, Indianapolis, IN; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN.
John ConcatoDepartment of Medicine, Yale School of Medicine, New Haven, CT; VA Clinical Epidemiology Research Center, VA Connecticut HCS, West Haven, CT.
James WareDepartment of Biostatistics, Harvard School of Public Health, Boston, MA.
Catherine M StoneyNational Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
Susan RedlineDepartment of Medicine, Harvard Medical School, Boston, MA; Division of Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Harvard University · USBeth Israel Deaconess Medical Center · USIndiana University School of MedicineNational Heart Lung and Blood Institute · USVA Connecticut Healthcare System · USYale University · US

Funding

A Planning Study: Sleep Apnea Intervention for Cardiovascular Disease ReductionU34HL105277 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MITTLEMAN, MURRAY A, REDLINE, SUSAN S. · 2010 to 2012
$2.5M
Sleep Apnea in TIA: Reducing Cardiovascular Risk with Positive Airway PressureU34HL105285 · NHLBI · YALE UNIVERSITY · PI BRAVATA, DAWN MARIE, YAGGI, HENRY KLAR · 2010 to 2012
$2.1M
Mentoring in Sleep Research and Sleep Interventions in Heart Disease, and StrokeK24HL132093 · NHLBI · YALE UNIVERSITY · PI YAGGI, HENRY KLAR · 2016 to 2020
$336k
NHLBI NIH HHS K24 HL132093NHLBI NIH HHS U34 HL105277NHLBI NIH HHS U34HL105277NHLBI NIH HHS U34 HL105285NHLBI NIH HHS U34HL105285
6 · The paper itself

Abstract

Obstructive sleep apnea (OSA) significantly impacts cardiovascular health, demonstrated by observational investigations showing an independently increased risk of ischemic heart disease, diabetes, hypertension, congestive heart failure, acute coronary syndrome, stroke, cardiovascular mortality, and all-cause mortality. Positive airway pressure (PAP), a medical therapy for sleep apnea, reverses airway obstruction and may help reduce cardiovascular risk. Prior to planning large phase III randomized controlled trials to test the impact of PAP on cardiovascular outcomes, several gaps in knowledge need to be addressed. This article describes 2 independent studies that worked collaboratively to fill these gaps. The populations, design features, and relative benefits/challenges of the 2 studies (SleepTight and BestAIR) are described. Both studies were encouraged to have multidisciplinary teams with expertise in behavioral interventions to improve PAP compliance. Both studies provide key information that will be useful to the research community in future large-scale, event-driven, randomized trials to evaluate the efficacy and/or effectiveness of strategies to identify and treat significant OSA for decreasing risk of major adverse cardiovascular events in high-risk patients.

Indexed as

Cardiovascular DiseasesSleep Apnea, ObstructiveContinuous Positive Airway PressureGlobal HealthHumansIncidencePatient ComplianceRandomized Controlled Trials as TopicRisk Factors

Identifiers

PMID26856225
PMCPMC4748381
OpenAlexW1627658166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.